METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION
TEVA CANADA LIMITED
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION in Canada?
Yes. METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 125MG has an active shortage reported to Health Canada (last updated February 13, 2020).
Why is METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION be available again?
The estimated resolution date (December 1, 2022) has passed, but the report has not been updated yet. Follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
SOLUMEDROL INJ 125MG STERILE MIXOVIAL
THE UPJOHN COMPANY OF CANADA
SOLU-MEDROL
PFIZER CANADA ULC
SOLUMEDROL INJ 40MG STERILE MIXOVIAL
THE UPJOHN COMPANY OF CANADA
MEDROL TOPICAL 0.25%
PFIZER CANADA ULC
MEDROL
PFIZER CANADA ULC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
Estimated Resolution
2022-12-01
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02231894
Strength
125MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAMUSCULAR INTRAVENOUS
Active Ingredient
METHYLPREDNISOLONE
Tier
Unrated
Last Updated
2020-02-13
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from TEVA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02143933
DIN 00834319
3.5MG · DIN 02438399
0.5MG · DIN 02301407
100MG · DIN 02420155
200MG · DIN 02420163
500MG · DIN 02247340
750MG · DIN 02247341
250MG · DIN 02247339
75MG · DIN 02303027
180MG · DIN 02370638
240MG · DIN 02370646